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Abstract
Purpose Aims of this cross-sectional study were to assess
health status and care dependency in patients with
advanced chronic obstructive pulmonary disease (COPD)
or chronic heart failure (CHF) and to identify correlates of
an impaired health status.
Methods The following outcomes were assessed in out-
patients with advanced COPD (n = 105) or CHF (n = 80):
clinical characteristics; general health status (EuroQol-5
Dimensions (EQ-5D); Assessment of Quality of Life
instrument (AQoL); Medical Outcomes Study 36-Item
Short-Form Health Survey (SF-36)); disease-specific health
status (St. Georges Respiratory Questionnaire (SGRQ),
Minnesota Living with Heart Failure Questionnaire
(MLHFQ)); physical mobility (timed ‘Up and Go’ test);
and care dependency (Care Dependency Scale).
Results Patients with advanced COPD or CHF have an
impaired health status and may be confronted with care
dependency. Multiple regression analyses have shown that
physical and psychological symptoms, care dependency
and number of drugs were correlated with impaired health
status in advanced COPD or CHF, while demographic and
clinical characteristics like age, gender, disease severity
and co-morbidities were not correlated.
Conclusions Clinical care should regularly assess symp-
tom burden and care dependency to identify patients with
advanced COPD or CHF at risk for an impaired health
status.
Keywords Chronic obstructive pulmonary disease 
Chronic heart failure  Health status  Health-related quality
of life  Care dependency  Functional status
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Introduction
Patient’s self-reported health status, defined as the impact
of health on a person’s ability to perform and derive fulf-
ilment from the activities of daily life, is an important
outcome [1]. Patients with advanced chronic obstructive
pulmonary disease (COPD) and chronic heart failure
(CHF) often have an impaired health status [2, 3]. Previous
studies suggest that health status of patients with advanced
COPD or CHF is equally or even more affected than health
status of patients with incurable cancer [4, 5]. Furthermore,
a decreased disease-specific health status is associated with
reduced rates of survival in COPD and CHF [6–8].
Management plans of patients with advanced COPD or
CHF should strive to optimize daily functioning and sta-
bilize disease-specific health status [9–11]. Identifying
clinical correlates of an impaired health status may allow
clinicians to better monitor health status and intervene
more effectively in patients with advanced COPD or CHF.
Several correlates of diminished general or disease-specific
health status in COPD or CHF have been suggested before,
like gender, age, educational level, symptoms, psycholog-
ical symptoms, disease severity, body mass index (BMI),
co-morbidities, smoking status and number of physician-
prescribed drugs [2, 3, 12–19]. However, currently avail-
able literature does not provide definitive evidence; hence,
it is still unknown whether and to what extent these clinical
correlates are interrelated in advanced COPD or CHF.
Health status includes patient’s self-reported quality of
life and functional status [1]. Functional impairment may
have significant consequences for patients and their fam-
ilies, such as social isolation of the patient and their loved
ones in the case of impaired mobility [20, 21]. One
observational study showed that patients with COPD or
CHF admitted to the hospital may experience disability in
basic and instrumental activities of daily living [22].
Impairment in the ability to perform normal daily tasks
can lead to patients becoming dependent on caregivers
[20]. A qualitative study of patients with end-stage COPD,
CHF or renal disease and their family caregivers showed
that increased dependency may lead to frustration,
depression and social isolation and increases the burden
on family caregivers [20]. Finally, there is some sugges-
tion that care dependency is associated with increased
mortality in patients hospitalized for an acute exacerbation
of COPD [8]. However, quantitative studies comparing
care dependency in clinically stable outpatients with
advanced COPD or CHF are lacking. Moreover, it remains
unknown whether and to what extent care dependency and
health status are interrelated in patients with advanced
COPD or CHF.
Aims of this cross-sectional study were to assess health
status and care dependency in patients with advanced
COPD or CHF and to identify correlates of impaired health
status. The present authors hypothesized a priori that care
dependency is an important correlate of general and dis-
ease-specific health status in patients with advanced COPD
or CHF, irrespective of the underlying disease.
Methods
Design
This cross-sectional study is part of a longitudinal study
concerning self-perceived symptoms and care needs in
patients with severe to very severe COPD or CHF and the
consequences for their closest relatives [23]. Details of the
methodology of this study and data on advance care
planning and symptom burden have been published before
[23–25].
The study was registered at the Dutch Trial Register
(NTR 1552).
Study population
Patients with advanced COPD or CHF were recruited by
their physician specialist during an outpatient consultation
of one academic and five general hospitals in the Nether-
lands in 2008 and 2009. Patients were eligible if they had a
diagnosis of advanced COPD (Global initiative for chronic
Obstructive Lung Disease (GOLD) stage III or IV) or CHF
(New York Heart Association (NYHA) class III or IV). For
patients who were referred for the study but refused par-
ticipation, data like severity of their disease, age and gender
were collected to compare characteristics of participating
and non-participating patients. All participating patients
gave written informed consent. The Medical Ethical Com-
mission of the Maastricht University Medical Cen-
tre ? (MUMC ?), Maastricht, the Netherlands, approved
this study (MEC 07-3-054).
Instruments
Patients were visited by a member of the research team in
their home environment. The following outcomes were
assessed: demographics; weight and height; self-reported
co-morbidities (Charlson comorbidity index [26]); current
medication; and forced expiratory volume in the first sec-
ond (FEV1). FEV1 was calculated from the flow–volume
curve measured by a handheld pulmonary spirometer [27].
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Symptoms in the previous 2 weeks were assessed using
visual analogue scales (VAS) [23, 24]. Severity of dyspnea
was measured using the modified Borg scale (range 0
(nothing at all) to 10 (maximal)) [28]. Symptoms of anx-
iety and depression were studied using the Hospital Anx-
iety and Depression Scale (HADS) [29]. The HADS is
divided into an anxiety subscale (HADS-A) and a depres-
sion subscale (HADS-D). Total scores for each subscale
range from 0 (optimal) to 21 (worst) points.
General health status
General health status was assessed using the self-admin-
istered questionnaires EuroQol-5 Dimensions (EQ-5D)
[30], Assessment of Quality of Life instrument (AQoL)
[31] and the Medical Outcomes Study 36-Item Short-Form
Health Survey (SF-36) [32].
EQ-5D is a five-item questionnaire consisting of
mobility, self-care, usual activity, pain/discomfort and
anxiety/depression [30]. Each item has three levels: no
problems, some problems and extreme problems. An index
score is provided which ranges from -0.59 (worst) to 1.0
(best) [30]. In addition, patients rated their current health
using VAS. VAS scores range from 0 (death or worst
possible health) to 100 (best possible health).
AQoL consists of 15 items divided into five domains:
illness; independent living; social relationships; physical
senses; and psychological well-being [31]. Total score
ranges from -0.04 (worst) to ?1.00 (best) [33].
SF-36 consists of 36 items divided into eight domains:
physical functioning; role-physical; bodily pain; general
health; vitality; social functioning; role-emotional; and
mental health. For each domain, scores range from 0
(worst) to 100 points (best) [32]. A physical component
summary measure and mental component summary mea-
sure are provided using norm-based methods with scores
from a Dutch general population [34]. These summary
measure scores are transformed to make a minimum and
maximum possible score of 0 and 100 points. All scores
below 50 points can be interpreted as below the general
population norm [32].
Disease-specific health status
Disease-specific health status was assessed in COPD
patients using the St. Georges Respiratory Questionnaire
(SGRQ) [35]. SGRQ provides three domain scores (symp-
toms; activities; and impact) and a total score, ranging from
0 (optimal) to 100 points (worst) [35].
In CHF patients, disease-specific health status was
assessed using the Minnesota Living with Heart Failure
Questionnaire (MLHFQ) [36]. MLHFQ consists of two
domains: physical (ranges from 0 (best) to 40 points (worst))
and emotional (ranges from 0 (best) to 25 points (worst)).
Total score ranges from 0 (best) to 105 points (worst) [36]. A
total score[45 points is defined as poor health status, 24–45
points as moderate health status, while\24 points represent
good health status [37].
Physical mobility
Physical mobility was assessed using the timed ‘Up and
Go’ (TUG) test [38]. TUG test measures in seconds the
time needed to stand up from a chair, walk a distance of
three metres, turn and walk back to the chair and sit down
again [38].
Care dependency
Care dependency was assessed using the Care Dependency
Scale (CDS). CDS consists of 15 items regarding basic and
instrumental activities of daily living, like personal care,
household activities, social and recreational activities [39].
The score ranges from 15 (worst) to 75 points (best).
Patients with a CDS score B68 points are considered as
care dependent [40].
Statistics
Categorical variables are described as frequencies, while
continuous variables have been tested for normality and are
presented as mean and standard deviation (SD) or median
and inter-quartile range (IQR). Categorical variables were
compared between patients with COPD and CHF using
Chi-square test. Continuous variables were compared
between patients with COPD and CHF using independent
sample T-test or Mann–Whitney U test, as appropriate.
CDS score was compared between COPD and CHF after
adjusting for age, gender, BMI and Charlson comorbidity
index score using linear regression analysis with robust
standard errors. To study correlates of general and disease-
specific health status, multiple regression analysis models
were developed for EQ-5D index score; AQoL total score;
SGRQ total score; and MLHFQ total score. The following
possible variables were tested for correlation with the
dependent variables: age, gender, disease, Charlson
comorbidity index score, FEV1, BMI, smoking status,
marital status, level of education, modified Borg scale,
number of self-perceived symptoms with VAS score
greater than 30 mm, long-term oxygen therapy (LTOT),
TUG score, HADS-A score, HADS-D score, CDS score,
presence of a family caregiver, need for assistance with
personal care by a professional caregiver and the number of
physician-prescribed drugs. The variables that showed
bivariate correlation with the dependent variables (Pearson
correlation coefficient [0.30) were entered as independent
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variables in the standard multiple regression analysis
models. Statistical analyses were performed using SPSS
17.0. STATA 11.1 was used for linear regression with
robust standard errors. A priori, a two-sided level of sig-
nificance was set at p B 0.05 [41].
See online supplement for details.
Results
General patient characteristics
In total, 105 COPD patients and 80 CHF patients were
included. The proportion of eligible patients who partici-
pated in the study was 62.9% for COPD and 46.0% for
CHF patients, P \ 0.05. Most COPD patients had very
severe COPD (GOLD stage IV: n = 77, 73.3%). CHF
patients were mainly classified as NYHA III (n = 74,
92.5%). On average, CHF patients were older and more
often living alone than COPD patients (Table 1).
Participating patients differed from patients who refused
participation in some respects. COPD and CHF participants
were younger than non-participants. Mean age of non-par-
ticipants was 69.7 (9.7) years for COPD and 78.5 (9.0) years
for CHF, P \ 0.05. In addition, COPD participants had
more advanced disease than patients who refused partici-
pation. Only 38.7% of non-participants was classified as
GOLD-stage IV, P \ 0.05. Finally, CHF participants were
more often men compared to non-participants (40.4%),
P \ 0.05.
General health status
General health status was considerably impaired in patients
with advanced COPD or CHF. Indeed, mean (SD) EQ-5D
index score was 0.51 (0.33) for COPD patients and 0.47
(0.32) for CHF patients, P [ 0.05. A higher proportion of
CHF compared to COPD patients reported problems
regarding pain/discomfort (Table 2). In addition, AQoL
scores showed impairment in general health status for both
diseases. However, mean (SD) total AQoL score was worse
for CHF than COPD patients (0.35 (0.26) vs. 0.46 (0.28),
respectively, P \ 0.05) (Table 3). AQoL physical senses
score was higher (better) for COPD than CHF patients.
Other AQoL domain scores were comparable for COPD
and CHF. The SF-36 showed impaired physical health
status compared with a Dutch standard population [34].
Mean (SD) SF-36 physical component summary measure
scores were comparable for COPD and CHF: 22.4 (9.6) and
22.2 (10.1) points, respectively, P [ 0.05. Mean (SD)
SF-36 mental component summary measure scores were
47.3 (14.5) points for COPD and 47.5 (14.6) points for
CHF, respectively, P [ 0.05. For most SF-36 domains,
impairment was comparable for COPD and CHF patients.
However, some differences were present. COPD patients
reported more impairment in the domain ‘general health’,
Table 1 Patient characteristics
COPD (n = 105) CHF (n = 80)
Gender (male), n (%) 65 (61.9%) 54 (67.5%)
Age (years), mean (SD) 66.3 (9.2)* 76.2 (8.3)
BMI (kg/m2), mean (SD)# 26.3 (6.7)* 28.6 (5.6)
Marital status (married/living with partner), n (%) 78 (74.3%)* 45 (56.3%)
Current smokers, n (%) 26 (24.8%)* 11 (13.8%)
FEV1 (% predicted), mean (SD)
# 34.1 (13.5)* 75.5 (24.5)
Charlson index (pts), mean (SD) 2.5 (1.7)* 4.4 (2.0)
Long-term oxygen therapy, n (%) 62 (59.0%)* 10 (12.5%)
Need for professional caregiver, n (%) 23 (21.9%)* 32 (40.0%)
Family caregiver, n (%) 90 (85.7%) 61 (76.3%)
Number of symptoms, mean (SD) 8.1 (3.7) 9.1 (3.5)
Borg scale (points), mean (SD) 4.8 (2.0)* 4.0 (2.5)
HADS-A score (points), mean (SD) 5.9 (4.5) 5.6 (4.3)
HADS-D score (points), mean (SD) 6.3 (4.0) 6.9 (4.0)
Number of physician-prescribed drugs, mean (SD)# 8.5 (3.9)* 10.8 (3.7)
Abbreviations: Body Mass Index (BMI); Chronic Obstructive Pulmonary Disease (COPD); Chronic Heart Failure (CHF); Forced Expiratory
Volume in the first second (FEV1); Hospital Anxiety and Depression Scale, Anxiety subscale (HADS-A); Hospital Anxiety and Depression Scale,
Depression subscale (HADS-D)
* P \ 0.05; # non-parametric statistical tests were used because of skewed data
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while CHF patients reported more impairment in the
domain ‘pain’ (Fig. 1).
Disease-specific health status
SGRQ scores and MLHFQ scores are shown in Fig. 2. Poor
health status ([45 points) was reported by 43 CHF patients
(53.7%), moderate health status (24–45 points) by 25 CHF
patients (31.3%) and good health status (\24 points) by 12
patients (15.0%) with advanced CHF.
Care dependency
CHF patients had a lower (worse) median (IQR) CDS score
than COPD patients: 65.0 (58.3–71.0) points versus 70.0
(63.0–73.0) points, respectively, P \ 0.05. However, CDS
score was comparable for COPD and CHF, after adjusting for
age, gender, BMI and Charlson comorbidity index score
(adjusted P = 0.57). The linear regression model showed an
association between age and CDS score (adjusted P = 0.03)
and Charlson comorbidity index score and CDS score
(adjusted P = 0.02). Older patients and patients with a higher
Charlson comorbidity index score had lower CDS scores.
Correlates of general health status
The number of self-perceived symptoms, TUG test, HADS-
A score, HADS-D score, Borg scale, CDS score, need for
assistance by a professional caregiver and the number of
physician-prescribed drugs showed bivariate correlation
with EQ-5D index score (Pearson correlation coefficient
[0.30). Age, gender, disease, Charlson comorbidity index
score, FEV1, BMI, smoking status, marital status, level of
education, LTOT and presence of a family caregiver did not
show a bivariate correlation (Pearson correlation coeffi-
cient B 0.30). The multiple regression analysis model, with
EQ-5D index score as dependent variable and the afore-
mentioned variables that showed bivariate correlation as
independent variables, was able to explain 56.4% of the
variance in EQ-5D index score. Patients who experienced
more symptoms, impairment in physical mobility, more
Table 2 General health status assessed with EuroQol-5 Dimensions (EQ-5D)
COPD (n = 105) CHF (n = 80)
EQ-5D index score, mean (SD) 0.51 (0.33) 0.47 (0.32)
EQ-5D VAS, mean (SD)# 62.6 (14.0) 62.1 (13.5)
EQ-5D Mobility, n (%) No problems 16 (15.2%) 8 (10.0%)
Some problems 87 (82.9%) 69 (86.2%)
Extreme problems 2 (1.9%) 3 (3.8%)
EQ-5D Self-care, n (%) No problems 43 (41.0%) 27 (33.8%)
Some problems 50 (47.6%) 38 (47.4%)
Extreme problems 12 (11.4%) 15 (18.8%)
EQ-5D Usual activities, n (%) No problems 18 (17.1%) 12 (15.0%)
Some problems 61 (58.1%) 50 (62.5%)
Extreme problems 26 (24.8%) 18 (22.5%)
EQ-5D Pain/discomfort*, n (%) No problems 57 (54.3%) 29 (36.2%)
Some problems 38 (36.2%) 43 (53.8%)
Extreme problems 10 (9.5%) 8 (10.0%)
EQ-5D Anxiety/depression, n (%) No problems 62 (59.1%) 44 (55.0%)
Some problems 33 (31.4%) 29 (36.2%)
Extreme problems 10 (9.5%) 7 (8.8%)
Abbreviations: Chronic Obstructive Pulmonary Disease (COPD); Congestive Heart Failure (CHF); EuroQol-5 Dimensions (EQ-5D); Visual
Analogue Scale (VAS)
* P \ 0.05; # non-parametric statistical tests have been used because of skewed data
Table 3 General health status assessed with Assessment of Quality
of Life (AQoL)
COPD (n = 105) CHF (n = 80)
AQoL illness 0.17 (0.17) 0.18 (0.14)
AQoL independent living 0.58 (0.30) 0.50 (0.30)
AQoL social relationships# 0.83 (0.20) 0.78 (0.27)
AQoL physical senses# 0.92 (0.11)* 0.84 (0.15)
AQoL psychological well-being# 0.87 (0.13) 0.85 (0.15)
AQoL total 0.46 (0.28)* 0.35 (0.26)
Values expressed as mean (SD)
Abbreviations: Assessment of Quality of Life instrument (AQoL);
Chronic Obstructive Pulmonary Disease (COPD); Congestive Heart
Failure (CHF)
* P \ 0.05; # non-parametric statistical tests have been used because
of skewed data
Qual Life Res (2011) 20:1679–1688 1683
123
symptoms of anxiety, a higher level of care dependency, the
need for a professional caregiver to assist with personal care
or patients who were using a higher number of physician-
prescribed drugs reported worse general health status, as
assessed with EQ-5D (Table 4).
The number of self-perceived symptoms, TUG test,
HADS-A score, HADS-D score, Borg scale, CDS score,
need for a professional caregiver and the number of phy-
sician-prescribed drugs also showed a bivariate correlation
with AQoL total score, while the other variables did not
show correlation. The standard multiple regression model
showed that the number of symptoms, HADS-D score,
CDS score, the need for a professional caregiver and the
number of physician-prescribed drugs explained 66.1% of
the variance in AQoL total score. Patients who experienced
more symptoms, more symptoms of depression, a higher
level of care dependency, the need for a professional
caregiver or patients who were using more physician-pre-
scribed drugs reported worse general health status, as
assessed with AQoL (Table 4).
See online supplement for multiple regression analysis
of general health status for COPD and CHF separately.
Correlates of disease-specific health status
The number of self-perceived symptoms, HADS-A score,
HADS-D score, Borg scale and CDS score showed bivariate
correlation with SGRQ total score (Pearson correlation
coefficient[0.30). A bivariate correlation was not found for
age, gender, Charlson comorbidity index score, FEV1, BMI,
smoking status, marital status, level of education, TUG test,
LTOT, presence of a family caregiver, the need for a pro-
fessional caregiver or the number of medications the subject
was using. The multiple regression analysis model showed
that the number of symptoms, HADS-D score, Borg scale
and CDS score were able to explain 57.5% of the variance
in SGRQ total score in advanced COPD (Table 5). COPD
patients who experienced increased symptoms, increased
symptoms of depression, increased severe dyspnea or a
higher level of care dependency reported more severe
impairment in disease-specific health status.
The number of self-perceived symptoms, HADS-A
score, HADS-D score, Borg scale and CDS score were
shown to exhibit bivariate correlation with MLHFQ total
score in patients with advanced CHF (Pearson correlation
coefficient[0.30). The multiple regression analysis model
showed that the number of symptoms, HADS-A score and
CDS score were statistically significantly correlated with
disease-specific health status. These variables predicted
52.9% of the variance in MLHFQ score. Patients with
advanced CHF, who experienced a higher number of
symptoms, more anxiety and a higher level of care














Fig. 1 General health status assessed with Medical Outcomes Study
36-Item Short-Form Health Survey (SF-36). Mean (SEM) domain
scores of the SF-36 in patients with advanced chronic obstructive
pulmonary disease (COPD, n = 105) or chronic heart failure (CHF,
n = 80). * P \ 0.05











Fig. 2 Disease-specific health status assessed with St. Georges
Respiratory Questionnaire (SGRQ) and Minnesota Living with Heart
Failure Questionnaire (MLHFQ). Mean (SEM) total and domain
scores of the SGRQ in patients with advanced chronic obstructive
pulmonary disease (COPD, n = 104) (left panel) and mean (SEM)
total and domain scores of the MLHFQ in patients with advanced
chronic heart failure (CHF, n = 80) (right panel)
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dependency reported more impairment in disease-specific
health status (Table 5).
Discussion
Key findings
The present study shows that patients with advanced COPD
or CHF have an impaired health status, irrespective of the
underlying disease. A substantial number of these patients
are confronted with care dependency. Symptom burden,
symptoms of anxiety and/or depression and care depen-
dency are correlates of general and disease-specific health
status in advanced COPD and/or CHF. In addition, the
number of physician-prescribed drugs is correlated with
general health status in advanced COPD and/or CHF.
Demographic and clinical characteristics like age, gender,
disease severity and co-morbidities are not correlated with
general or disease-specific health status.
Table 4 Correlates of general health status: results of standard multiple regression models
Model Correlates Standardized Beta P value
EQ-5D index score (R2 = 0.564, P \ 0.0005) Number of symptoms -0.149 0.022
TUG test -0.228 0.000
HADS-A -0.182 0.007
HADS-D -0.033 0.640
Borg scale -0.096 0.083
CDS 0.253 0.000
Need professional caregiver -0.157 0.006
Number of drugs -0.124 0.024
AQol total score (R2 = 0.661, P \ 0.0005) Number of symptoms -0.192 0.001
TUG test -0.006 0.914
HADS-A -0.072 0.228
HADS-D -0.170 0.006
Borg scale -0.086 0.078
CDS 0.347 0.000
Need professional caregiver -0.225 0.000
Number of drugs -0.137 0.005
n = 185
Abbreviations: Assessment of Quality of Life instrument (AQoL); Care Dependency Scale (CDS); EuroQol-5 Dimensions (EQ-5D); Hospital
Anxiety and Depression Scale, Anxiety subscale (HADS-A); Hospital Anxiety and Depression Scale, Depression subscale (HADS-D); Timed ‘Up
and Go’ test (TUG test)
Table 5 Correlates of disease-specific health status: results of standard multiple regression models
Model Correlates Standardized beta P value
COPD n = 104* SGRQ total score (R2 = 0.575, P \ 0.0005) Number of symptoms 0.259 0.003
HADS-A -0.027 0.768
HADS-D 0.213 0.018
Borg scale 0.358 0.000
CDS -0.225 0.004
CHF n = 80 MLHFQ total score (R2 = 0.529, P \ 0.0005) Number of symptoms 0.251 0.020
HADS-A 0.311 0.005
HADS-D 0.074 0.511
Borg scale 0.165 0.076
CDS -0.212 0.020
Abbreviations: Care Dependency Scale (CDS); Chronic Obstructive Pulmonary Disease (COPD); Congestive Heart Failure (CHF); Hospital
Anxiety and Depression Scale, Anxiety subscale (HADS-A); Hospital Anxiety and Depression Scale, Depression subscale (HADS-D); Minnesota
Living with Heart Failure Questionnaire (MLHFQ); St. Georges Respiratory Questionnaire (SGRQ); Timed ‘Up and Go’ test (TUG test)
* 1 patient excluded because of missing values
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Health status, care dependency and correlates
of health status
The present study has shown that age, gender, co-mor-
bidities, lung function, smoking status, marital status, level
of education, LTOT and presence of a family caregiver
were not correlated with general and/or disease-specific
health status in patients with advanced COPD or CHF.
These findings conflict with some of the currently available
literature. Previously, it was suggested that impaired gen-
eral health status is associated with female gender and
higher age in patients with CHF [13, 16]. However, most
patients in these studies had mild to moderate CHF [13,
16], while the present study included only patients with
severe to very severe CHF. Spencer and colleagues showed
an association between smoking status and SGRQ total
score in patients with COPD [17]. We did not confirm these
findings in our sample of patients with advanced COPD.
Other studies suggested an association between FEV1 and
total SGRQ score in patients with severe COPD [14, 15],
another finding that was not confirmed in the present study.
Indeed, the present study showed lack of correlation
between FEV1 and SGRQ total score (Spearman’s rho -
0.093 (P = 0.354)). Then again, the present study showed
also lack of correlation between FEV1 and EQ-5D index
score (Spearman’s rho 0.087 (P = 0.387)) or AQoL total
score (Spearman’s rho 0.161 (P = 0.107)) in patients with
advanced COPD. Oga and colleagues have shown that
change in health status and change in pulmonary function
were not related [42]. In a recent study in clinically stable
patients with COPD, severity of airflow limitation was
poorly related to health status [43]. Thus, there is sub-
stantial evidence that FEV1 is not appropriate for identi-
fying patients with advanced COPD at increased risk for an
impaired health status.
Clinical correlates, like symptom burden, symptoms of
anxiety and/or depression, care dependency and number of
physician-prescribed drugs were able to explain 56% and
66% of EQ-5D index score and AQoL total score,
respectively. Higher symptom burden is associated with
worse general and disease-specific health status in patients
with advanced COPD or CHF. The correlation between
severity of dyspnea and disease-specific health status in
COPD confirms previous findings [14, 15, 18, 44]. Fur-
thermore, the correlation between symptom distress and
health status has been shown before in patients with COPD
or CHF and emphasizes again the importance of addressing
symptom burden in patients with advanced COPD or CHF
[2, 3, 19, 45].
The present study shows that care dependency is a major
correlate of general and disease-specific health status in
patients with advanced COPD or CHF. Regular assessment
of care dependency should be part of routine clinical care
for patients with advanced COPD or CHF. Management
programmes aimed at optimizing health status of patients
with advanced COPD or CHF should assess impairments in
basic and instrumental activities of daily living and should
try to minimize care dependency.
Limitations of the present study
The study population consisted of a convenience sample of
patients. While the majority of eligible COPD patients
were willing to participate, the response rate for CHF
patients was below 50%. The current response rate con-
firms the previously reported difficulty of recruitment of
older patients with CHF [46] and may limit the general-
izability of the results.
Some differences were present between COPD and CHF
patients. Although differences between COPD and CHF
patients in age, marital status and smoking status are sta-
tistically significant, the clinical relevance for the present
study may be limited, as is shown by the lack of correlation
between health status and age, marital status or smoking
status. Furthermore, patients with co-morbidities were not
excluded from the analyses. Indeed, co-morbidities in
patients with COPD and CHF are common [47–49] and
might have influenced the results of the present study.
Finally, the present study is a cross-sectional study, and
health status and care dependency are likely to change
during the course of the disease [7, 50]. A longitudinal
follow-up study is warranted to further reveal how health
status and care dependency change over time in patients
with advanced COPD or CHF.
Conclusions and implications
This study demonstrates that health status is considerably
impaired in patients with advanced COPD or CHF and
confirms our hypothesis that care dependency is an
important correlate of general and disease-specific health
status. Patients confronted with care dependency, patients
who experience more physical and psychological symp-
toms or patients who are using a higher number of physi-
cian-prescribed drugs are at risk for having an impaired
health status. Therefore, clinicians should routinely assess
symptom burden as well as care dependency in patients
with advanced COPD or CHF.
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